Polynovo Limited (AU:PNV) has released an update.
PolyNovo Limited has achieved a milestone with a record-breaking revenue of $A10.1 million in April 2024, demonstrating significant growth with U.S. sales up by approximately 75% from the same time last year and Rest of World sales increasing by roughly 68%. The company’s expansion into new markets and the application of their products in various plastic and reconstructive surgeries have contributed to their global impact, now reaching over 42,000 patients across 39 countries.
For further insights into AU:PNV stock, check out TipRanks’ Stock Analysis page.
